The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats
Abstract
Abstract —We recently reported that the activation of nuclear factor-κB (NF-κB) promotes inflammation in rats harboring both human renin and angiotensinogen genes (double-transgenic rats [dTGR]). We tested the hypothesis that the antioxidant pyrrolidine dithiocarbamate (PDTC) inhibits NF-κB and ameliorates renal and cardiac end-organ damage. dTGR feature hypertension, severe renal and cardiac damage, and a 40% mortality rate at 7 weeks. Electrophoretic mobility shift assay showed increased NF-κB DNA binding activity in hearts and kidneys of dTGR. Chronic PDTC (200 mg/kg SC) treatment decreased blood pressure (162±8 versus 190±7 mm Hg; P =0.02) in dTGR compared with dTGR controls. The cardiac hypertrophy index was also significantly reduced (4.90±0.1 versus 5.77±0.1 mg/g; P <0.001). PDTC reduced 24-hour albuminuria by >95% (2.5±0.8 versus 57.1±8.7 mg/d; P <0.001) and prevented death. Vascular injury was ameliorated in small renal and cardiac vessels. Electrophoretic mobility shift assay showed that PDTC inhibited NF-κB binding activity in heart and kidney, whereas AP-1 activity in the kidney was not decreased. dTGR exhibited increased left ventricular c- fos and c- jun mRNA expression. PDTC treatment reduced c- fos but not c- jun mRNA. Immunohistochemistry showed increased p65 NF-κB subunit expression in the endothelium and smooth muscle cells of damaged small vessels, as well as infiltrating cells in glomeruli, tubules, and collecting ducts of dTGR. PDTC markedly reduced the immunoreactivity of p65. PDTC also prevented the NF-κB–dependent transactivation of the intercellular adhesion molecule ICAM-1 and inducible nitric oxide synthase. Monocyte infiltration was markedly increased in dTGR kidneys and hearts. Chronic treatment reduced monocyte/macrophage infiltration by 72% and 64%, respectively. Thus, these results demonstrate that PDTC inhibits NF-κB activity, ameliorates inflammation, and protects against angiotensin II-induced end-organ damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Antioxidant and redox regulation of gene transcription
Sen, C. K., & Packer, L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635688 · Cited by 1,981
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro
Abate, C., Patel, L., Rauscher, F. J., & Curran, T. (1990) · Science · doi:10.1126/science.2118682 · Cited by 1,573
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
Meyer, M., Schreck, R., & Baeuerle, P. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05850.x · Cited by 1,313
Pathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,269
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
Hobbs, A. J., Higgs, A., & Moncada, S. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.191 · Cited by 596
Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-894 · Cited by 584
Ushio-Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., & Griendling, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22699 · Cited by 558
Nakamura, K., Fushimi, K., Kouchi, H., Mihara, K., Miyazaki, M., Ohe, T., & Namba, M. (1998) · Circulation · doi:10.1161/01.cir.98.8.794 · Cited by 510
The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.
Lindpaintner, K., & Ganten, D. (1991) · Circulation Research · doi:10.1161/01.res.68.4.905 · Cited by 422
Self-citationLiu, S. F., Ye, X., & Malik, A. B. (1999) · Circulation · doi:10.1161/01.cir.100.12.1330 · Cited by 346
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
Zabel, U., Henkel, T., Silva, M. S., & Baeuerle, P. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05646.x · Cited by 319
Ruiz‐Ortega, M., Bustos, C., Hernández-Presa, M. Á., Lorenzo, Ó., Plaza, J. J. G., & Egido, J. (1998) · PubMed · Cited by 284
Nobel, C. S. I., Kimland, M., Lind, B., Orrenius, S., & Slater, A. F. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26202 · Cited by 280
GALTER, D., MIHM, S., & DRÖGE, W. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18776.x · Cited by 274
Liu, S. F., Ye, X., & Malik, A. B. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3976 · Cited by 252
Abbate, M., Zoja, C., Corna, D., Capitanio, M., Bertani, T., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971213 · Cited by 247
Ruiz-Ortega, M., Bustos, C., Hernández-Presa, M. A., Lorenzo, O., Plaza, J. J., & Egido, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.430 · Cited by 230
Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin Hypertension
Mervaala, E. M. A., Müller, D. N., Park, J.-K., Schmidt, F., Löhn, M., Breu, V., Dragun, D., Ganten, D., Haller, H., & Luft, F. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.389 · Cited by 223
Self-citationHypertension-Induced End-Organ Damage: A New Transgenic Approach to an Old Problem
Luft, F. C., Mervaala, E., Müller, D. N., Gross, V., Schmidt, F., Park, J. K., Schmitz, C., Lippoldt, A., Breu, V., Dechend, R., et al. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.212 · Cited by 205
Self-citationKrappmann, D., Wulczyn, F. G., & Scheidereit, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01061.x · Cited by 190
Rangan, G. K., Wang, Y., Tay, Y.-C., & Harris, D. C. H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00529.x · Cited by 173
The Cytokine Responsive Vascular Smooth Muscle Cell Enhancer of Inducible Nitric Oxide Synthase
Spink, J., Cohen, J., & Evans, T. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29541 · Cited by 162
High Human Renin Hypertension in Transgenic Rats
Bohlender, J. M., Fukamizu, A., Lippoldt, A., Nomura, T., Dietz, R., Ménard, J., Murakami, K., Luft, F. C., & Ganten, D. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.428 · Cited by 130
Self-citationHernández-Presa, M. Á., Bustos, C., Ortego, M., Tuñón, J., Ortega, L. M., & Egido, J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65697-0 · Cited by 124
Moriguchi, Y., Matsubara, H., Mori, Y., Murasawa, S., Masaki, H., Maruyama, K., Tsutsumi, Y., Shibasaki, Y., Tanaka, Y., Nakajima, T., et al. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1073 · Cited by 120
Takahashi, T., Taniguchi, T., Konishi, H., Kikkawa, U., Ishikawa, Y., & Yokoyama, M. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h1927 · Cited by 109
Dragun, D., Tullius, S. G., Park, J. K., Maasch, C., Lukitsch, I., Lippoldt, A., Groß, V., Luft, F. C., & Haller, H. G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00026.x · Cited by 99
Self-citationLocal Angiotensin II Generation in the Rat Heart
Müller, D. N., Fischli, W., Clozel, J., Hilgers, K. F., Bohlender, J. M., Ménard, J., Busjahn, A., Ganten, D., & Luft, F. C. (1998) · Circulation Research · doi:10.1161/01.res.82.1.13 · Cited by 98
Self-citationRosen, P., Du, X., & Tschöpe, D. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006876607566 · Cited by 93
Marumo, T., Schini‐Kerth, V. B., Brandes, R. P., & Busse, R. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.1083 · Cited by 89
Muñoz, C., Castellanos, M. C., Alfranca, A., Vara, A., Esteban, M. A., Redondo, J. M., & Landázuri, M. O. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3587 · Cited by 82
Perrella, M. A., Patterson, C., Tan, L., Yet, S., Hsieh, C.-M., Yoshizumi, M., & Lee, M.-E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13776 · Cited by 79
Integrins, Adhesion, and Cardiac Remodeling
Hsueh, W. A., Law, R. E., & Yung, P. S. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.176 · Cited by 60
Hamaguchi, A., Kim, S., Izumi, Y., Zhan, Y., Yamanaka, S., & Iwao, H. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.126 · Cited by 57
Scheidegger, K. J., Du, J., & Delafontaine, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3522 · Cited by 53
Roy‐Chaudhury, P., Hillis, G. S., Mcdonald, S., Simpson, J. G., & Power, D. A. (1997) · Kidney International · doi:10.1038/ki.1997.309 · Cited by 45
The role of L-arginine in hypertension and nephrotoxicity
Klahr, S. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199809000-00010 · Cited by 14
Cited by
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Reactive oxygen species in vascular biology: implications in hypertension
Touyz, R. M., & Schiffrin, E. L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0696-7 · Cited by 646
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020218 · Cited by 567
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Metadata
- Authors
- Muller, D. N., Dechend, R., Mervaala, E. M. A., Park, J.-K., Schmidt, F., Fiebeler, A., Theuer, J., Breu, V., Ganten, D., Haller, H., & Luft, F. C.
- Venue
- Hypertension
- Published
- 2000-01
- Volume
- 35
- Issue
- 1
- Pages
- 193-201
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2151577160
- Cited by
- 405
- References
- 43
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.